FasL/Fas and TNF/TNFR interactions in the regulation of immune responses and disease.
Lynch
D H
DH
Dept. of Immunobiology, Immunex Corporation, Seattle, WA 98101, USA.
Campbell
K A
KA
Miller
R E
RE
Badley
A D
AD
Paya
C V
CV
D000818:Animals; D017209:Apoptosis; D001402:B-Lymphocytes / Q000276:immunology*; D002478:Cells, Cultured; D004194:Disease; D053222:Fas Ligand Protein; D006678:HIV / Q000502:physiology; D015658:HIV Infections / Q000276:immunology; D006801:Humans; D008562:Membrane Glycoproteins / Q000502:physiology*; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology*; D012016:Reference Values; D013601:T-Lymphocytes / Q000276:immunology* / Q000821:virology; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology*; D019014:fas Receptor / Q000502:physiology*
C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D019014:fas Receptor